{"meshTagsMajor":["Point Mutation"],"meshTags":["Anus Neoplasms","Benzamides","Amino Acid Substitution","Pyrimidines","Female","Point Mutation","Lysine","Humans","Piperazines","Remission Induction","Aged","Melanoma","Proto-Oncogene Proteins c-kit","Intestinal Mucosa","Dose-Response Relationship, Drug","Glutamic Acid","Neoplasm Metastasis","Imatinib Mesylate"],"meshMinor":["Anus Neoplasms","Benzamides","Amino Acid Substitution","Pyrimidines","Female","Lysine","Humans","Piperazines","Remission Induction","Aged","Melanoma","Proto-Oncogene Proteins c-kit","Intestinal Mucosa","Dose-Response Relationship, Drug","Glutamic Acid","Neoplasm Metastasis","Imatinib Mesylate"],"genes":["K642E KIT"],"publicationTypes":["Case Reports","Letter"],"title":"Dose-dependent, complete response to imatinib of a metastatic mucosal melanoma with a K642E KIT mutation.","pubmedId":"18510589"}